https://www.selleckchem.com/pr....oducts/pf-07265807.h
PURPOSE To report a case of reversible corneal endothelial abnormalities following treatment with netarsudil. OBSERVATION A 68-year-old woman presented with the complaint of blurred vision soon after starting treatment with the fixed dose combination of netarsudil and latanoprost (FC-netarsudil-latanoprost). She had been receiving the fixed dose combination of dorzolamide and timolol and latanoprost for primary open-angle glaucoma until her ophthalmologist switched latanoprost to FC-netarsudil-latanoprost 2 months before referral to
Beğen
Yorum Yap
Paylaş
